Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network

Blood Cancer Journal, Published online: 08 October 2019; doi:10.1038/s41408-019-0245-1Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network
Source: Blood Cancer Journal - Category: Hematology Authors: Source Type: research